Joshua C Doloff
Joshua C Doloff
Assistant Professor, Dept. of Biomedical Engineering, Johns Hopkins University
Verified email at jhu.edu - Homepage
Title
Cited by
Cited by
Year
Size-and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates
O Veiseh, JC Doloff, M Ma, AJ Vegas, HH Tam, AR Bader, J Li, E Langan, ...
Nature materials 14 (6), 643-651, 2015
5102015
Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice
AJ Vegas, O Veiseh, M Gürtler, JR Millman, FW Pagliuca, AR Bader, ...
Nature medicine 22 (3), 306-311, 2016
4702016
Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates
AJ Vegas, O Veiseh, JC Doloff, M Ma, HH Tam, K Bratlie, J Li, AR Bader, ...
Nature biotechnology 34 (3), 345-352, 2016
2832016
Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primates
JC Doloff, O Veiseh, AJ Vegas, HH Tam, S Farah, M Ma, J Li, A Bader, ...
Nature materials 16 (6), 671-680, 2017
1322017
Core–shell hydrogel microcapsules for improved islets encapsulation
M Ma, A Chiu, G Sahay, JC Doloff, N Dholakia, R Thakrar, J Cohen, ...
Advanced healthcare materials 2 (5), 667-672, 2013
1262013
Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques
MA Bochenek, O Veiseh, AJ Vegas, JJ McGarrigle, M Qi, E Marchese, ...
Nature biomedical engineering 2 (11), 810-821, 2018
1162018
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
L Miao, L Li, Y Huang, D Delcassian, J Chahal, J Han, Y Shi, K Sadtler, ...
Nature biotechnology 37 (10), 1174-1185, 2019
1142019
Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug
TT Dang, AV Thai, J Cohen, JE Slosberg, K Siniakowicz, JC Doloff, M Ma, ...
Biomaterials 34 (23), 5792-5801, 2013
902013
VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity–induced tumor regression
JC Doloff, DJ Waxman
Cancer research 72 (5), 1103-1115, 2012
822012
Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression
CS Chen, JC Doloff, DJ Waxman
Neoplasia 16 (1), 84-W27, 2014
672014
Reduction of measurement noise in a continuous glucose monitor by coating the sensor with a zwitterionic polymer
X Xie, JC Doloff, V Yesilyurt, A Sadraei, JJ McGarrigle, M Omami, ...
Nature biomedical engineering 2 (12), 894-906, 2018
662018
Neutrophil responses to sterile implant materials
S Jhunjhunwala, S Aresta-DaSilva, K Tang, D Alvarez, MJ Webber, ...
PloS one 10 (9), e0137550, 2015
662015
Modular ‘Click‐in‐Emulsion’Bone‐Targeted Nanogels
DA Heller, Y Levi, JM Pelet, JC Doloff, J Wallas, GW Pratt, S Jiang, ...
Advanced Materials 25 (10), 1449-1454, 2013
632013
Conditionally replicating adenoviruses for cancer treatment
Y Jounaidi, JC Doloff, DJ Waxman
Current cancer drug targets 7 (3), 285-301, 2007
612007
Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations
S Farah, JC Doloff, P Müller, A Sadraei, HJ Han, K Olafson, K Vyas, ...
Nature materials 18 (8), 892-904, 2019
502019
Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy
HI Swanson, VCO Njar, Z Yu, DJ Castro, FJ Gonzalez, DE Williams, ...
Drug Metabolism and Disposition 38 (4), 539-544, 2010
422010
Endothelial siRNA delivery in nonhuman primates using ionizable low–molecular weight polymeric nanoparticles
OF Khan, PS Kowalski, JC Doloff, JK Tsosie, V Bakthavatchalu, CB Winn, ...
Science advances 4 (6), eaar8409, 2018
402018
A facile and versatile method to endow biomaterial devices with zwitterionic surface coatings
V Yesilyurt, O Veiseh, JC Doloff, J Li, S Bose, X Xie, AR Bader, M Chen, ...
Advanced healthcare materials 6 (4), 1601091, 2017
342017
Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT
JC Doloff, DJ Waxman
Cancer gene therapy 18 (3), 153-166, 2011
312011
Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions
JC Doloff, DJ Waxman, Y Jounaidi
Human gene therapy 19 (12), 1383-1399, 2008
302008
The system can't perform the operation now. Try again later.
Articles 1–20